Prostate cancer moves in silence, offering no early warning to the men it inhabits — and yet the myths surrounding its detection may be as dangerous as the disease itself. Across India, leading urologists have stepped into the gap between fear and knowledge, clarifying that a single PSA number is neither a sentence nor a reassurance, but the beginning of a conversation shaped by age, ancestry, and individual risk. The deeper truth they offer is ancient in medicine: the absence of symptoms has never been the same as the presence of health.
Top Urologists Debunk Prostate Cancer Myths in Live Q&A on Screening and PSA Testing
Prostate cancer develops silently in its early stages
Mark
So if prostate cancer has no symptoms early on, how is a man supposed to know he needs screening?
Mimi
That's exactly why age and family history matter so much. You don't wait to feel sick. You get screened on a schedule, starting at 55 if you're average risk, earlier if your father or brother had it.
Luke
But the screening itself—the PSA test—doesn't actually diagnose cancer, right? It just flags something to investigate?
Mimi
Correct. PSA is a signal, not a diagnosis. Lots of benign things raise it—infections, enlargement, even cycling. That's why doctors look at the whole picture.
Mark
So an elevated PSA doesn't mean I have cancer?
Mimi
No. Most men with elevated PSA don't have cancer. And some men with cancer have normal PSA. It's one piece of information.
Luke
What about family history? How much does that actually increase risk?
Mimi
If your father had it, your risk roughly doubles. If multiple relatives had it, or if they were diagnosed young, the risk is even higher.
Mark
At what age should someone with a family history start getting screened?
Mimi
Between 40 and 45, depending on how strong the family history is. And they should talk to their urologist about genetic testing too.
Luke
And if someone has symptoms like burning during urination—is that prostate cancer?
Mimi
Almost never, in isolation. That's usually a UTI or infection. Prostate cancer symptoms, when they do show up, come late and usually with other signs like weight loss or bone pain.
Mark
So the key is screening before symptoms appear?
Mimi
Exactly. Catch it while it's still localized, and outcomes are much better.
Le Pouls
- Prostate cancer can grow for years without pain, urinary trouble, or any signal a man would notice — making the widespread belief that 'feeling fine means being fine' a quietly dangerous assumption.
- The PSA test, widely misunderstood as a yes-or-no cancer detector, is actually a sensitive but non-specific signal that benign conditions like enlarged prostate, infections, and even prolonged cycling can trigger just as readily as cancer.
- Men with a first-degree relative diagnosed with prostate cancer carry roughly double the risk and are urged to begin screening a full decade earlier — between 40 and 45 — rather than waiting for the standard age of 55.
- Six urologists from major Indian hospitals are pushing back against entrenched myths through direct public engagement, stressing that an elevated PSA opens an investigation, not a verdict, and that MRI and biopsy follow only when clinical context warrants.
- The panel's unified message is landing as a call for informed, individualized screening — where family history, genetic markers, and a sustained dialogue with a urologist replace both complacency and panic.
Prostate cancer moves in silence, offering no early warning to the men it inhabits — and yet the myths surrounding its detection may be as dangerous as the disease itself. Across India, leading urologists have stepped into the gap between fear and knowledge, clarifying that a single PSA number is neither a sentence nor a reassurance, but the beginning of a conversation shaped by age, ancestry, and individual risk. The deeper truth they offer is ancient in medicine: the absence of symptoms has never been the same as the presence of health.
Prostate cancer is one of the most common cancers affecting men worldwide, yet it remains shrouded in misconceptions that discourage the very screening that saves lives. To address this, six leading urologists from major hospitals across India recently answered the questions men most commonly — and most anxiously — ask.
The first and most important truth they offered: prostate cancer develops silently. There are no early symptoms to feel, no pain to prompt a visit. A man can carry the disease for years without knowing. This is why age and screening timelines matter. For men at average risk, the panel recommends a baseline PSA test and digital rectal exam beginning at 55, repeated every one to two years if results are normal. For men with a first-degree relative diagnosed with prostate cancer — who face roughly double the risk — screening should begin between 40 and 45. The risk rises further with multiple affected relatives, early-onset diagnoses in the family, or a history of breast and ovarian cancer suggesting inherited mutations like BRCA2.
The second truth is equally important: an elevated PSA does not mean cancer. This, the doctors agreed, is the most persistent myth. PSA is prostate-specific, not cancer-specific. Benign prostatic enlargement, infections, inflammation, urinary retention, recent catheterization, and even prolonged cycling can all raise PSA levels. Conversely, some men with cancer have entirely normal PSA readings. Results must always be interpreted alongside age, PSA density and velocity, and findings from a physical exam. Persistent elevation may prompt an MRI, and biopsy follows only if imaging raises genuine concern.
Symptoms, when they finally appear, tend to arrive late and are often caused by something else entirely. Burning urination points far more readily to infection than cancer. Bone pain typically signals advanced disease, not early-stage illness. The urologists advised evaluating common causes first and investigating further only when red flags — elevated PSA, abnormal rectal exam, age, or family history — are present.
The through-line from all six physicians was the same: screening is not diagnosis, and an abnormal result is a signal to look closer, not a verdict. The most powerful tool available to any man is an informed, ongoing conversation with his urologist — one that turns a number on a lab report into genuine medical understanding.
Prostate cancer kills quietly. A man can carry it for years without knowing—no pain, no warning, nothing to feel. Yet it remains one of the most common cancers affecting men worldwide, wrapped in confusion and half-truths that keep people from getting screened. To cut through the noise, six leading urologists from major hospitals across India recently sat down to answer the questions men actually ask: Am I at risk? What does a PSA test really mean? Can I have cancer without symptoms?
The answer to that last question is yes. Dr. Srinivas Krishnaswamy, a consultant urologist at Manipal Hospital in Yelahanka, put it plainly: prostate cancer develops silently in its early stages, which is precisely why many men wrongly assume their prostate is fine because they feel fine. The disease doesn't announce itself with urinary problems or pain. It simply grows. This is not a reason to panic at 35—the incidence of prostate cancer below age 30 is only around 5 percent—but it is a reason to understand that age matters, and screening matters more.
The standard recommendation from the panel: men at average risk should begin screening at 55 years old, starting with a baseline PSA test and digital rectal exam, then repeating every one to two years if results are normal. But the timeline shifts for men with family history or certain genetic markers. Those with a first-degree relative diagnosed with prostate cancer face roughly double the risk and should start screening between 40 and 45. The risk climbs higher still if multiple relatives were affected, if any were diagnosed before age 60, or if the family carries a history of breast or ovarian cancer—signs that an inherited gene mutation like BRCA2 may be at work. Dr. Karandeep Guleria, a consultant urologist at Max Super Speciality Hospital in Delhi, emphasized that men in these categories should discuss genetic testing and individualized surveillance with their urologist.
But here is where the confusion deepens: an elevated PSA does not mean cancer. This is, by the doctors' own account, the biggest myth. The prostate-specific antigen test can detect changes in the gland before symptoms appear, which is valuable. Yet PSA is prostate-specific, not cancer-specific. Many men with elevated PSA never develop cancer. Many men with cancer have normal PSA levels. Dr. Chandan M N, a consultant in urology and uro-oncology at Apollo One in Bengaluru, stressed that results must always be interpreted alongside age, PSA density, velocity, and findings from a digital rectal exam. If PSA remains persistently elevated, doctors may order an MRI of the prostate, followed by biopsy only if the imaging looks suspicious.
The reason for this caution is simple: benign conditions raise PSA all the time. Benign prostatic hyperplasia—enlargement of the prostate—does it. So do infections, inflammation, urinary tract infections, urinary retention, recent catheterization, ejaculation, and even prolonged cycling. A man can have a high PSA and no cancer. He can have cancer and a normal PSA. This is why context matters. Dr. Gokulakrishnan P J, lead consultant in the urology department at Aster Whitefield Hospital in Bangalore, noted that when prostate cancer is caught while still localized—before it spreads—treatment outcomes and survival rates improve dramatically compared to advanced disease.
Symptoms, when they do appear, often arrive late. Burning during urination, called dysuria, is far more likely to signal a urinary tract infection, prostatitis, or sexually transmitted infection than cancer. Persistent lower back and hip pain is usually musculoskeletal. Prostate cancer can cause bone pain, but typically only in advanced stages, and usually alongside urinary symptoms, weight loss, or fatigue. Dr. Sumit Gahlawat, director of urology at Dharamshila Narayana Superspeciality Hospital in Delhi, advised evaluating common causes first, then investigating further only if red flags exist—elevated PSA, abnormal rectal exam, age, or family history.
The through-line from all six doctors was consistent: prostate cancer develops without symptoms, which makes early detection through screening crucial for men at risk. But screening is not diagnosis. An abnormal result is a signal to look closer, not a verdict. The conversation between a man and his urologist—informed by age, family history, genetic factors, and individual risk—is what transforms a number on a lab report into actual medical wisdom.
Citations marquantes
Prostate cancer develops without symptoms during its initial phase, which makes it a fundamental fact about this disease.— Dr. Srinivas Krishnaswamy, Manipal Hospital
PSA is prostate-specific; however, it is not cancer-specific. The majority of men with elevated PSA will not have prostate cancer, and a majority of men with prostate cancer will have a normal PSA level.— Dr. Chandan M N, Apollo One
Envie de l'histoire complète ?
Lire l'original sur Times Now ↗
Health & Medicine